Business · 08/09/2023Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting for Pulmonary-Allergy Drugs Advisory Committee
Summary
The FDA is hosting a public meeting of the Pulmonary-Allergy Drugs Advisory Committee to gather input on regulatory issues, with a public docket established for comments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →